Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling.
about
Beta-adrenoceptor stimulation potentiates insulin-stimulated PKB phosphorylation in rat cardiomyocytes via cAMP and PKAA network-oriented perspective on cardiac calcium signalingIs physical activity able to modify oxidative damage in cardiovascular aging?Biophysical Fragment Screening of the β 1 -Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Designβ2-adrenoceptor transfection enhances contractile reserve of isolated rat ventricular myocytes exposed to chronic isoprenaline stimulation by improving β1-adrenoceptor responsivenessConfinement of β(1)- and β(2)-adrenergic receptors in the plasma membrane of cardiomyocyte-like H9c2 cells is mediated by selective interactions with PDZ domain and A-kinase anchoring proteins but not caveolae.Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies.beta-Adrenergic activation of electrogenic K+ and Cl- secretion in guinea pig distal colonic epithelium proceeds via separate cAMP signaling pathways.β-Adrenergic receptor-PI3K signaling crosstalk in mouse heart: elucidation of immediate downstream signaling cascades.Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms.Impact of combined clenbuterol and metoprolol therapy on reverse remodelling during mechanical unloading.β₂ AR agonists in treatment of chronic heart failure: long path to translation.Broad-scale phosphoprotein profiling of beta adrenergic receptor (β-AR) signaling reveals novel phosphorylation and dephosphorylation eventsCyclic AMP is both a pro-apoptotic and anti-apoptotic second messengerTHE ROLE OF β-ADRENERGIC RECEPTORS IN HEART FAILURE: DIFFERENTIAL REGULATION OF CARDIOTOXICITY AND CARDIOPROTECTION.The design, synthesis and pharmacological characterization of novel β₂-adrenoceptor antagonists.Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wasting.Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures.Fenoterol enantiomers do not possess beneficial therapeutic properties of their racemic mixture in the rat model of post myocardial infarction dilated cardiomyopathy.β adrenergic receptor modulation of neurotransmission to cardiac vagal neurons in the nucleus ambiguusAbsence of the inhibitory G-protein Galphai2 predisposes to ventricular cardiac arrhythmia.Organization of beta-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes.CXCR4 gene transfer prevents pressure overload induced heart failureContribution of pertussis toxin to the pathogenesis of pertussis diseaseDesipramine pretreatment improves sympathetic remodeling and ventricular fibrillation threshold after myocardial ischemiaRole of beta-adrenergic receptor signaling and desensitization in heart failure: new concepts and prospects for treatment.Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways.Intracellular signaling pathways pave roads to recovery for mood disorders.Beta adrenergic receptors in keratinocytes.Regulation of cardiac nitric oxide signaling by nuclear β-adrenergic and endothelin receptors.Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytesThe 27-kDa heat shock protein confers cytoprotective effects through a beta 2-adrenergic receptor agonist-initiated complex with beta-arrestin.Adrenergic signaling and oxidative stress: a role for sirtuins?Adrenergic activation of electrogenic K+ secretion in guinea pig distal colonic epithelium: involvement of beta1- and beta2-adrenergic receptorsAdrenergic activation of electrogenic K+ secretion in guinea pig distal colonic epithelium: desensitization via the Y2-neuropeptide receptorCardiac Adenylyl Cyclase and Phosphodiesterase Expression Profiles Vary by Age, Disease, and Chronic Phosphodiesterase Inhibitor Treatment.β-blockers as endocrine disruptors: the potential effects of human β-blockers on aquatic organisms.The Role of Inhibitory G Proteins and Regulators of G Protein Signaling in the in vivo Control of Heart Rate and Predisposition to Cardiac Arrhythmias.Structure-based and fragment-based GPCR drug discovery.Xamoterol impairs hippocampus-dependent emotional memory retrieval via Gi/o-coupled β2-adrenergic signaling.
P2860
Q24632097-8E22534C-F6AC-4FB9-8859-EF6C0FB6D104Q27023389-AAF644A1-FAF3-4D77-AD51-EAB97F7FEC69Q27025850-FCD13769-A001-4598-97AD-35EF05D5F677Q27676919-C91EE812-705A-45C8-BEE8-4DF57E5C83FCQ28573247-736CA699-D5DE-49F8-9469-CC42DD2789ABQ30503440-98590D54-F47D-43D9-8A02-FBE870236051Q33847602-2651CA55-E0E3-40D5-9B70-1508A75AC05DQ33994734-CC6D431A-25D0-460A-B6EB-9D2C4A0A1923Q34058699-F1C63D1E-8312-4CDC-BE8A-13DAF8B5465BQ34253155-3930EF46-3262-46E0-AF48-E70BF7A783CFQ34275561-00BBB570-56EB-46E9-8588-6924E94E2E14Q34634348-17092279-34CB-4DE0-A8E0-AE0CCCFCBEE0Q35067711-67CC0D7E-5C2B-40F1-809C-8C36A24FAFAAQ35074567-E1F83C39-31CD-426E-A714-E656C4F885FFQ35104064-252B63F3-0F87-49EF-97AD-5F15090E9CE1Q35216471-005DCAB9-9A12-418D-9412-A62ADC18CC43Q35545370-C64B08F1-36D2-4671-837E-681A052C426BQ35621909-EE4A4CBB-10AE-4A5E-822D-06E131D6245AQ35933471-6B1A53E8-D7BF-4C13-BC26-815FE29A125EQ35981081-C18F0774-13A1-4A90-80BE-80788055282AQ36106715-415B00C1-F724-4F45-83B4-761715A4CE86Q36117806-16A1313B-B95E-4DC9-9BBA-DBCD8AB1E2AFQ36132472-92E5CF31-D605-4253-B185-7CE0A51C0552Q36226458-C47A2E89-A4A8-449C-B835-45BFE9B63EDBQ36316410-F105F2A8-5F98-4A8E-9EEF-1C0BF85E3DECQ36484933-3ABA2541-535D-4AC5-8E72-0A993B7A0D01Q36575695-3668C7B6-1AD6-4E13-86F9-08824F428AA8Q36939418-4684BB0D-B7A5-4E5E-9FB8-45D1B2B90529Q36954846-7EF9F0C0-954C-4E46-973E-93D2C716F7E3Q37075419-AF355CD3-36C5-4676-A01A-EA7AF08E9BDBQ37126029-A4F4485C-1D60-497A-89EC-4B4E4456B4B5Q37199137-F7912A5D-345F-4D09-AD85-ABC745F535B7Q37289500-67099760-801D-4C07-93C5-098171336D56Q37297959-1100733D-5DF2-4225-970F-0CDB79DC7AC4Q37297963-B79C4A35-3E3E-4F38-B3E1-1C8FFE08E867Q37742299-18CABFA1-7CD0-47CB-A0EC-C2CCD316954EQ37849264-DF0CEEA7-A0E8-4849-9624-F36A8418D928Q38025384-E5ECE2D7-8DBB-4B55-914A-C94C7B0AB449Q38172457-ACF8B0F5-A502-413F-AED0-B262CDED3ECDQ38302843-1E20F1BF-9231-40CE-AC2E-8B93C7426D48
P2860
Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Emerging concepts and therapeu ...... ic receptor subtype signaling.
@ast
Emerging concepts and therapeu ...... ic receptor subtype signaling.
@en
type
label
Emerging concepts and therapeu ...... ic receptor subtype signaling.
@ast
Emerging concepts and therapeu ...... ic receptor subtype signaling.
@en
prefLabel
Emerging concepts and therapeu ...... ic receptor subtype signaling.
@ast
Emerging concepts and therapeu ...... ic receptor subtype signaling.
@en
P2093
P1476
Emerging concepts and therapeu ...... ic receptor subtype signaling.
@en
P2093
Ming Zheng
Rui-Ping Xiao
Weizhong Zhu
P304
P356
10.1016/J.PHARMTHERA.2005.04.006
P577
2005-06-24T00:00:00Z